Molecular biological characterisation of the novel Rifampicin inactivation mechanism in Nocardioform bacteria

Description

Rifampicin is one of the major antibiotics used in the treatment of Mycobacterium tuberculosis. This organism causes tuberculosis. Other related nocardioform bacteria which include the Rhodococci are opportunistic pathogens in AIDS patients. These organisms cause tuberculosis-like disease and are currently treated with rifampicin and other drugs. The presence of a low level rifampicin resistance mechanism was identified in seven rhodococcal strains and five other related and unrelated bacteria. Abbreviated Abstract. Open document to view full version] / GR2017

Links & Downloads

1. Andersen, Susan Jean (1996) Molecular biological characterisation of the novel Rifampicin inactivation mechanism in Nocardioform bacteria, University of Witwatersrand, Johannesburg, <http://wiredspace.wits.ac.za/handle/10539/22180>
2. http://hdl.handle.net/10539/22180

Tags

Nocardia

Rifampin

Molecular biology

Molecular cloning

Antitubercular agents--Research

Additional Fields

Identifer	oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:wits/oai:wiredspace.wits.ac.za:10539/22180
Date	January 1996
Creators	Andersen, Susan Jean
Source Sets	South African National ETD Portal
Language	English
Detected Language	English
Type	Thesis
Format	Online resource (227 leaves), application/pdf